Creative Financial Designs Inc Amarin Corp Plcuk Transaction History

Creative Financial Designs Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 06, 2020	SELL	$3.64 - $7.76 $8,972 - $19,128	-2,465 Closed	0 $0
Q2 2020 Jul 23, 2020	BUY	$4.78 - $8.26 $2,868 - $4,956	600 Added 32.17%	2,465 $17,000
Q4 2019 Jan 17, 2020	SELL	$13.94 - $24.12 $1,603 - $2,773	-115 Reduced 5.81%	1,865 $40,000
Q4 2018 Jan 24, 2019	BUY	$12.41 - $22.98 $3,536 - $6,549	285 Added 16.81%	1,980 $27,000
Q2 2018 Jul 13, 2018	BUY	$2.68 - $3.48 $4,234 - $5,498	1,580 Added 1373.91%	1,695 $5,000
Q4 2016 Mar 14, 2018	BUY	N/A	115	115 $0

176

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $254M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Creative Financial Designs Inc , based on Form 13F filings with the SEC.

Stay updated on Creative Financial Designs Inc with notifications on news.